Graft failure after allogeneic hematopoietic stem cell transplantation: Definition and risk factors

被引:1
|
作者
Alcazer, Vincent [1 ,2 ]
de Latour, Regis Peffault [3 ,4 ]
Ader, Florence [5 ,6 ]
Labussiere-Wallet, Helene [1 ]
机构
[1] Hosp Civils Lyon, Dept Hematol Clin, 165 Chemin Grand Revoyet, F-69310 Pierre Benite, France
[2] Ctr Rech Cancerol Lyon, Inserm U1052, CNRS 5286, F-69008 Lyon, France
[3] Hop St Louis, AP HP, Serv Hematol Greffe, F-75006 Paris, France
[4] Univ Paris Diderot, F-75007 Paris, France
[5] Hosp Civils Lyon, Serv Malad Infect, F-69004 Lyon, France
[6] Ctr Int Rech Infectiol, Inserm U1111, CNRS 5308, F-69008 Lyon, France
关键词
Allogeneic hematopoietic; stem cell transplantation; Graft failure; Rejection; Infections; ANTI-HLA ANTIBODIES; BONE-MARROW-TRANSPLANTATION; PERIPHERAL-BLOOD; RETROSPECTIVE ANALYSIS; FRANCOPHONE SOCIETY; APLASTIC-ANEMIA; DONOR; IMPACT; OUTCOMES; ENGRAFTMENT;
D O I
10.1016/j.bulcan.2019.03.009
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Allogeneic hematopoietic stem cell transplantation is the only curative therapy for numerous malignant and non-malignant haematological diseases. A sustained engraftment of the donor stem cells is essential for transplant success and overall outcome. Graft failure is a rare but severe event after allogeneic hematopoietic stem cell transplantation. While different risk factors such as underlying disease, graft source or HLA matching have been found to be consistently associated with graft failure, other factors such as ABO mismatch graft-versus-host disease prophylaxis or infections, particularly viral reactivations, are more controversial. In this article, we review the different factors associated with graft failure.
引用
收藏
页码:574 / 583
页数:10
相关论文
共 50 条
  • [31] Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation
    Nordlander, Anna
    Uhlin, Michael
    Ringden, Olle
    Kumlien, Gunilla
    Hauzenberger, Dan
    Mattsson, Jonas
    TRANSPLANT IMMUNOLOGY, 2011, 25 (2-3) : 153 - 158
  • [32] Mini-review - Second hematopoietic stem cell transplantation for the treatment of graft failure, graft rejection or relapse after allogeneic transplantation
    Wolff, SN
    BONE MARROW TRANSPLANTATION, 2002, 29 (07) : 545 - 552
  • [33] Comparison of immunosuppressant regimens in salvage cord blood transplantation for graft failure after allogeneic hematopoietic stem cell transplantation
    Harada, Kaito
    Fuji, Shigeo
    Seo, Sachiko
    Uchida, Naoyuki
    Kawakita, Toshiro
    Yano, Shingo
    Ozawa, Yukiyasu
    Yoshioka, Satoshi
    Onishi, Yasushi
    Noguchi, Yuma
    Onizuka, Makoto
    Matsuhashi, Yoshiko
    Kimura, Takafumi
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Terakura, Seitaro
    Nakasone, Hideki
    BONE MARROW TRANSPLANTATION, 2021, 56 (02) : 400 - 410
  • [34] Immunological Basis of Bone Marrow Failure after Allogeneic Hematopoietic Stem Cell Transplantation
    Masouridi-Levrat, Stavroula
    Simonetta, Federico
    Chalandon, Yves
    FRONTIERS IN IMMUNOLOGY, 2016, 7
  • [35] Risk-Factor Analysis of Poor Graft Function after Allogeneic Hematopoietic Stem Cell Transplantation
    Xiao, Yang
    Song, Jiayin
    Jiang, Zujun
    Li, Yonghua
    Gao, Yang
    Xu, Wenning
    Lu, Ziyuan
    Wang, Yaochun
    Xiao, Haowen
    INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2014, 11 (06): : 652 - 657
  • [36] Second haploidentical stem cell transplantation for primary graft failure
    Giammarco, Sabrina
    Raiola, Anna Maria
    Di Grazia, Carmen
    Bregante, Stefania
    Gualandi, Francesca
    Varaldo, Riccardo
    Chiusolo, Patrizia
    Sora, Federica
    Sica, Simona
    Laurenti, Luca
    Metafuni, Elisabetta
    Innocenti, Idanna
    Autore, Francesco
    Murgia, Barbara
    Bacigalupo, Andrea
    Angelucci, Emanuele
    BONE MARROW TRANSPLANTATION, 2021, 56 (06) : 1291 - 1296
  • [37] Anti-HLA Antibody Levels Are Associated With the Risk of Graft Failure After Allogeneic Hematopoietic Stem Cell Transplant
    Basturk, Bilkay
    Kasar, Mutlu
    Yeral, Mahmut
    Kavuzlu, Miray
    EXPERIMENTAL AND CLINICAL TRANSPLANTATION, 2017, 15 : 219 - 223
  • [38] Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation
    Uderzo, Cornelio
    Bonanomi, Sonia
    Busca, Alessandro
    Renoldi, Mila
    Ferrari, Pierantonio
    Iacobelli, Massimo
    Morreale, Giuseppe
    Lanino, Edoardo
    Annaloro, Claudio
    Della Volpe, Aldo
    Alessandrino, Paolo
    Longoni, Daniela
    Locatelli, Franco
    Sangalli, Haidi
    Rovelli, Attilio
    TRANSPLANTATION, 2006, 82 (05) : 638 - 644
  • [39] Comparison of the outcomes after haploidentical and cord blood salvage transplantations for graft failure following allogeneic hematopoietic stem cell transplantation
    Harada, Kaito
    Fuji, Shigeo
    Seo, Sachiko
    Kanda, Junya
    Ueki, Toshimitsu
    Kimura, Fumihiko
    Kato, Koji
    Uchida, Naoyuki
    Ikegame, Kazuhiro
    Onizuka, Makoto
    Matsuoka, Ken-ichi
    Doki, Noriko
    Kawakita, Toshiro
    Onishi, Yasushi
    Yano, Shingo
    Fukuda, Takahiro
    Takanashi, Minoko
    Kanda, Yoshinobu
    Atsuta, Yoshiko
    Ogata, Masao
    BONE MARROW TRANSPLANTATION, 2020, 55 (09) : 1784 - 1795
  • [40] Outcomes of Lung Transplantation after Allogeneic Hematopoietic Stem Cell Transplantation
    Cheng, Guang-Shing
    Edelman, Jeffrey D.
    Madtes, David K.
    Martin, Paul J.
    Flowers, Mary E. D.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (08) : 1169 - 1175